Xpel Inc

XPEL remains in a clear Stage 4 decline with a decisive support failure, lower highs/lows, and downward‐sloping EMAs acting as resistance. Short-term price is rejected at the 9/21/50 DMAs, confirming bearish momentum. No mean‐reversion eligibility exists. Execute a sell now into the resistance zone defined by broken support and moving averages.

• ↑Q1 revenue grew 13.1% YoY to $117.4M, driven by U.S. and APAC markets.
• ↑Maintained a 43.7% gross margin, reflecting effective cost controls and inventory management.
• ↓P/E of ~25 and PEG of 1.79 suggest valuation may be stretched.